Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 2
2013 4
2014 4
2015 6
2016 6
2017 5
2018 6
2019 7
2020 9
2021 6
2022 7
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

63 results
Results by year
Filters applied: . Clear all
Page 1
Current RNA-based Therapeutics in Clinical Trials.
Zhou LY, Qin Z, Zhu YH, He ZY, Xu T. Zhou LY, et al. Curr Gene Ther. 2019;19(3):172-196. doi: 10.2174/1566523219666190719100526. Curr Gene Ther. 2019. PMID: 31566126 Review.
Recent advances in lentiviral vectors for gene therapy.
Wang X, Ma C, Rodríguez Labrada R, Qin Z, Xu T, He Z, Wei Y. Wang X, et al. Among authors: he z. Sci China Life Sci. 2021 Nov;64(11):1842-1857. doi: 10.1007/s11427-021-1952-5. Epub 2021 Jul 14. Sci China Life Sci. 2021. PMID: 34708326 Review.
Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells.
Hong W, Yang J, Zou J, Bi Z, He C, Lei H, He X, Li X, Alu A, Ren W, Wang Z, Jiang X, Zhong K, Jia G, Yang Y, Yu W, Huang Q, Yang M, Zhou Y, Zhao Y, Kuang D, Wang J, Wang H, Chen S, Luo M, Zhang Z, Lu T, Chen L, Que H, He Z, Sun Q, Wang W, Shen G, Lu G, Zhao Z, Yang L, Yang J, Wang Z, Li J, Song X, Dai L, Chen C, Geng J, Gou M, Chen L, Dong H, Peng Y, Huang C, Qian Z, Cheng W, Fan C, Wei Y, Su Z, Tong A, Lu S, Peng X, Wei X. Hong W, et al. Among authors: he z. Cell Mol Immunol. 2022 May;19(5):577-587. doi: 10.1038/s41423-022-00845-6. Epub 2022 Mar 10. Cell Mol Immunol. 2022. PMID: 35273357 Free PMC article.
Gene Therapy (Part II).
He ZY, Jia XB. He ZY, et al. Curr Gene Ther. 2020;20(2):83. doi: 10.2174/156652322002200821100006. Curr Gene Ther. 2020. PMID: 32951571 No abstract available.
Gene Therapy (Part I).
Jia XB, He ZY. Jia XB, et al. Curr Gene Ther. 2020;20(1):4. doi: 10.2174/156652322001200604150311. Curr Gene Ther. 2020. PMID: 32603275 No abstract available.
Nanomedicines for Overcoming Cancer Drug Resistance.
Hu T, Gong H, Xu J, Huang Y, Wu F, He Z. Hu T, et al. Among authors: he z. Pharmaceutics. 2022 Aug 1;14(8):1606. doi: 10.3390/pharmaceutics14081606. Pharmaceutics. 2022. PMID: 36015232 Free PMC article. Review.
Progress in the treatment of infantile hemangioma.
Chen ZY, Wang QN, Zhu YH, Zhou LY, Xu T, He ZY, Yang Y. Chen ZY, et al. Ann Transl Med. 2019 Nov;7(22):692. doi: 10.21037/atm.2019.10.47. Ann Transl Med. 2019. PMID: 31930093 Free PMC article. Review.
CRISPR/Cas9-mediated correction of human genetic disease.
Men K, Duan X, He Z, Yang Y, Yao S, Wei Y. Men K, et al. Among authors: he z. Sci China Life Sci. 2017 May;60(5):447-457. doi: 10.1007/s11427-017-9032-4. Epub 2017 May 3. Sci China Life Sci. 2017. PMID: 28534256 Review.
63 results